News

US Medicare lays out timeline for third round of drug price negotiations
The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...
Medicare to publish drugs selected for third round of price negotiations by Feb. 1
The Centers for Medicare & Medicaid Services (CMS) has sought public comments as the agency plans to list up to 15 additional ...
Health Affairs17h
In Price Negotiations, Medicare Should Reassess How It Determines A ‘Qualifying Single Source Drug’
Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...
How soon will drug prices drop? RFK Jr. says timeline depends on big pharma
Health and Human Services Secretary Robert F. Kennedy Jr. said that bringing the cost of prescription drugs to levels seen in ...
HealthLeaders Media23m
Medicare lays out timeline for third round of drug price negotiations
CMS said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year. For the first time, the list would include drugs ...
Health Affairs4d
Costs Of Extending The Small Molecule Exemption Period In Medicare Drug Price Negotiation
Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...
Wall Street Journal knocks Trump on expanding drug price controls: ‘Worst idea since tariffs’
The editorial board of the Wall Street Journal is criticizing President Trump over an executive order expanding drug price ...